1. Home
  2. ANIX vs MDIA Comparison

ANIX vs MDIA Comparison

Compare ANIX & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$3.00

Market Cap

103.9M

Sector

Health Care

ML Signal

N/A

Logo Mediaco Holding Inc.

MDIA

Mediaco Holding Inc.

N/A

Current Price

$0.88

Market Cap

90.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ANIX
MDIA
Founded
1982
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
103.9M
90.7M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ANIX
MDIA
Price
$3.00
$0.88
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $9.67
N/A
AVG Volume (30 Days)
★ 203.7K
6.8K
Earning Date
09-09-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 12.82
N/A
EPS
N/A
★ N/A
Revenue
$210,000.00
★ $133,336,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 39.52
52 Week Low
$2.32
$0.54
52 Week High
$5.46
$1.64

Technical Indicators

Market Signals
Indicator
ANIX
MDIA
Relative Strength Index (RSI) 51.58 42.77
Support Level $2.77 $0.86
Resistance Level $3.09 $1.06
Average True Range (ATR) 0.18 0.08
MACD 0.05 -0.01
Stochastic Oscillator 47.65 37.06

Price Performance

Historical Comparison
ANIX
MDIA

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment.

Share on Social Networks: